Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer - Blackwell, K L; Burstein, H J; Storniolo, A M (J ClinOncol, 2010)
et al.